Recent Updates
Recently added Catalysts
MYGN Positive Sentiment Score: 70/100

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Wednesday, January 8, 2025 1 min read
Key Takeaway: Myriad Genetics, Inc. (NASDAQ: MYGN) will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025. This presentation will showcase the company's advancements in genetic testing and precision medicine. Investors and attendees can access the presentation via a live webcast on Myriad's investor relations website, with an archived version available later the same day. This highlights Myriad's commitment to sharing advancements and insights in the healthcare domain.

Market Sentiment Analysis

POSITIVE FACTORS

  • Myriad Genetics is recognized as a leader in genetic testing and precision medicine.
  • The company's participation in a major healthcare conference suggests strong industry engagement.
  • Live webcast availability indicates transparency and accessibility for investors.

Full Press Release Details

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET).
The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will be available later that day.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Tags

Healthcare Conference

Frequently Asked Questions

When will Myriad Genetics present at the J.P. Morgan Healthcare Conference?

Myriad Genetics will present on Wednesday, Jan. 15, at 3:45 PM PT.

How can I watch Myriad Genetics' presentation?

The presentation will be available via live webcast on Myriad’s investor site.

What does Myriad Genetics specialize in?

Myriad Genetics specializes in genetic testing and precision medicine.

What services does Myriad Genetics provide?

Myriad offers genetic tests to assess disease risk and guide treatment decisions.

Where can I find more information about Myriad Genetics?

For more details, visit Myriad's official website at www.myriad.com.

Tags: MYGN Viatris Investor Conferences Healthcare Myriad Genetics J.P. Morgan healthcare conference genetic testing precision medicine
Last updated: Jan 8, 2025